These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33330916)

  • 1. Connecting the Dots: Translating the Vaginal Microbiome Into a Drug.
    Lagenaur LA; Hemmerling A; Chiu C; Miller S; Lee PP; Cohen CR; Parks TP
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S296-S306. PubMed ID: 33330916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease.
    Hemmerling A; Wierzbicki MR; Armstrong E; Cohen CR
    Sex Transm Dis; 2024 Jun; 51(6):437-440. PubMed ID: 38733973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
    van de Wijgert J; Verwijs MC
    BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal Lactobacillus crispatus persistence following application of a live biotherapeutic product: colonization phenotypes and genital immune impact.
    Armstrong E; Hemmerling A; Miller S; Huibner S; Kulikova M; Crawford E; Castañeda GR; Coburn B; Cohen CR; Kaul R
    Microbiome; 2024 Jun; 12(1):110. PubMed ID: 38907268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
    Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
    Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal fungi are associated with treatment-induced shifts in the vaginal microbiota and with a distinct genital immune profile.
    Armstrong E; Hemmerling A; Miller S; Huibner S; Kulikova M; Liu R; Crawford E; Castañeda GR; Coburn B; Cohen CR; Kaul R
    Microbiol Spectr; 2024 Aug; 12(8):e0350123. PubMed ID: 38912808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis.
    Borgdorff H; Armstrong SD; Tytgat HL; Xia D; Ndayisaba GF; Wastling JM; van de Wijgert JH
    PLoS One; 2016; 11(3):e0150767. PubMed ID: 26963809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vaginal microbiota: what have we learned after a decade of molecular characterization?
    van de Wijgert JH; Borgdorff H; Verhelst R; Crucitti T; Francis S; Verstraelen H; Jespers V
    PLoS One; 2014; 9(8):e105998. PubMed ID: 25148517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.
    Cohen CR; Wierzbicki MR; French AL; Morris S; Newmann S; Reno H; Green L; Miller S; Powell J; Parks T; Hemmerling A
    N Engl J Med; 2020 May; 382(20):1906-1915. PubMed ID: 32402161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally administrated
    Qi F; Fan S; Fang C; Ge L; Lyu J; Huang Z; Zhao S; Zou Y; Huang L; Liu X; Liang Y; Zhang Y; Zhong Y; Zhang H; Xiao L; Zhang X
    Front Immunol; 2023; 14():1125239. PubMed ID: 37575226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal Microbiota.
    Mendling W
    Adv Exp Med Biol; 2016; 902():83-93. PubMed ID: 27161352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
    Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
    Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal microbiome.
    Buchta V
    Ceska Gynekol; 2018; 83(5):371-379. PubMed ID: 30848142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human vaginal microbiota colonization is regulated by female sex hormones in a mouse model.
    Rahman N; Mian MF; Nazli A; Kaushic C
    Front Cell Infect Microbiol; 2023; 13():1307451. PubMed ID: 38156321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatment.
    Zhu M; Frank MW; Radka CD; Jeanfavre S; Xu J; Tse MW; Pacheco JA; Kim JS; Pierce K; Deik A; Hussain FA; Elsherbini J; Hussain S; Xulu N; Khan N; Pillay V; Mitchell CM; Dong KL; Ndung'u T; Clish CB; Rock CO; Blainey PC; Bloom SM; Kwon DS
    Cell; 2024 Sep; 187(19):5413-5430.e29. PubMed ID: 39163861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal colonization of women after oral administration of Lactobacillus crispatus strain NTCVAG04 from the human microbiota.
    DE Leo V; Lazzeri E; Governini L; Cuppone AM; Colombini L; Teodori L; Ciprandi G; Iannelli F; Pozzi G
    Minerva Obstet Gynecol; 2023 Oct; 75(5):432-439. PubMed ID: 35686637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising Prebiotic Candidate Established by Evaluation of Lactitol, Lactulose, Raffinose, and Oligofructose for Maintenance of a Lactobacillus-Dominated Vaginal Microbiota.
    Collins SL; McMillan A; Seney S; van der Veer C; Kort R; Sumarah MW; Reid G
    Appl Environ Microbiol; 2018 Mar; 84(5):. PubMed ID: 29269494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of vaginal microbes and classification of the vaginal microbiome.
    Zhu B; Spaine KM; Edupuganti L; Matveyev A; Serrano MG; Buck GA
    bioRxiv; 2023 Aug; ():. PubMed ID: 37645743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial.
    Armstrong E; Hemmerling A; Miller S; Burke KE; Newmann SJ; Morris SR; Reno H; Huibner S; Kulikova M; Nagelkerke N; Coburn B; Cohen CR; Kaul R
    Lancet Microbe; 2022 Jun; 3(6):e435-e442. PubMed ID: 35659905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.